Pharmaceutical 6,5 Heterobicyclic Ring Derivatives

Jag Paul Heer (Inventor), Michal Sarah Hallside (Inventor), Adam Peter Smalley (Inventor), Josep Llaveria Cros (Inventor), Benedicte Lallemand (Inventor), Martin Alexander Lowe (Inventor), Xianfu Li (Inventor), Anthony Richardson (Inventor), Robert James Townsend (Inventor)

Research output: Patent

31 Downloads (Pure)


The invention relates to 6,5 heterobicyclic ring derivatives of formula (I), processes for preparing them, pharmaceutical compositions containing them and their use for the treatment of inflammatory conditions driven by STING activation, such as, but not confined to, SLE and geographic atrophy.
Original languageEnglish
Patent numberWO/2019/158731
IPCA61K 31/437 2006.1,A61K 31/4375 2006.1,A61K 31/519 2006.1,A61K 31/4365 2006.1,C07D 471/04 2006.1,C07D 498/04 2006.1,C07D 513/04 2006.1,A61P 29/00 2006.1,A61P 19/00 2006.1
Priority date16/08/19
Filing date15/02/19
Publication statusPublished - 22 Aug 2019


Dive into the research topics of 'Pharmaceutical 6,5 Heterobicyclic Ring Derivatives'. Together they form a unique fingerprint.

Cite this